Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

This Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte) in Patients With Cartilage Defects in Their Knees.

NCT02539056 is registered in ClinicalTrials.gov with Cellontech Co., Ltd. as lead sponsor.

NCT NCT02539056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02539056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
This Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte) in Patients With Cartilage Defects in Their Knees.
Lead sponsor
Cellontech Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2012
Completion date
March 18, 2016
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, traumatic arthritis